News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medivation, Inc. (MDVN) Announces Participation at Upcoming Investor Conferences



12/3/2012 11:57:37 AM

SAN FRANCISCO, CA--(Marketwire - November 29, 2012) - Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conferences:

  • David Hung, M.D., president and chief executive officer, will present at the Deutsche Bank BioFEST Conference on December 3 at 9:35am Eastern Time in Boston, MA.
  • David Hung, M.D., president and chief executive officer, will present at the JP Morgan Healthcare Conference on January 7 at 4:30pm Pacific Time in San Francisco, CA.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.


Contacts:
Patrick Machado
Chief Business & Financial Officer
(415) 829-4101

Anne Bowdidge
Sr. Director
Investor Relations
(650) 218-6900


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES